Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion type Assertion NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_head.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion description "[Together, our results suggest that MCM-2 is a noval therapeutic target of TSA in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_provenance.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion evidence source_evidence_literature NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_provenance.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion SIO_000772 23770000 NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_provenance.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion wasDerivedFrom befree-20140225 NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_provenance.
- NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_assertion wasGeneratedBy ECO_0000203 NP231687.RAvjAIUm-80N1xc9P_VjpK2sgQ4qRIXXO7DJXrxlP-3NY130_provenance.